Retatrutide Is a First-in-Its-Class Medication Retatrutide is a triple agonist medication, meaning it works on three different hormone receptors in the body: GLP-1, GIP, and glucagon leading some experts to call it a triple-G drug
After all, there are over 100 originator drugs and almost as many biosimilars in the pipeline, many of which will never progress to commercialisation, but some of which will further push the boundaries on patient convenience, efficacy and indication spectrum
Tashiro Y, Sato K, Watanabe T, Nohtomi K, Terasaki M, Nagashima M et al (2014) A glucagon-like peptide-1 analog liraglutide suppresses macrophage foam cell formation and atherosclerosis
Despite these efforts, I struggled to get meaningful results and lose adequate weight
Conversely, with daily medications like liraglutide, skipping doses may result in a quicker reduction of effects
IGF-1 elevation from full HGH use is associated with increased cell proliferation risk, fluid retention, and carpal tunnel syndrome at therapeutic doses